HB 241-FN - VERSION ADOPTED BY BOTH BODIES
7Jan2026... 2990h
05/07/2026 1622s
2025 SESSION
25-0358
05/08
HOUSE BILL 241-FN
SPONSORS: Rep. Nagel, Belk. 6; Rep. T. Dolan, Rock. 16; Rep. Lundgren, Rock. 16; Rep. Palmer, Sull. 2
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill requires health carriers to develop, in accordance with guidelines established by the insurance department, a program to provide access to a broad spectrum of covered pain management services for the management of chronic pain.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
7Jan2026... 2990h
05/07/2026 1622s 25-0358
05/08
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Five
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Statement of Findings and Purpose.
I. The general court recognizes the following:
(a) The causes of the opioid crisis are complex and multifactorial.
(b) One of the major causes was the failure of the health care system, as a whole, to provide meaningful access to a broad range of non-opioid, non-interventional evidence-based therapies including complimentary alternative medicine provided by licensed professionals as either single modality therapy or integrative care for those who suffer from acute, chronic, and/or end of life pain.
(c) Executive and legislative entities both at the federal and state level pursued public health polices to combat the crisis which, in effect, abandoned those in pain, particularly those on opioid therapies, by creating barriers to opioid therapy without creating access to non-opioid therapies resulting in unnecessary and extensive morbidity and mortality for those patients.
(d) While government based and commercial insurers do provide some access to these therapies, the availability is limited and insufficient to address the scope of the problem.
(e) While the litmus test for what therapies should be made available is evidence-based, it is concerning that a double standard is used between therapies provided by allopathic and non-allopathic providers in determining strength of evidence required, and this double standard unfairly favors allopathic providers.
II. The purpose of this act is to both increase access to these therapies in a cost-effective, evidence-based manner in the commercial insurance market and to level the evidence-based standards used in deciding which therapies should be available.
2 New Section; Managed Care Law; Development of a Comprehensive Program of Pain Management Services for the Management of Chronic Pain. Amend RSA 420-J by inserting after section 7-e the following new section:
420-J:7-f Development of a Comprehensive Program of Pain Management Services for the Management of Chronic Pain.
I. Health carriers shall develop, in accordance with guidelines established by the insurance department, a program to provide access to a broad spectrum of covered pain management services, including, but not limited to, non-medication, nonsurgical treatment modalities, and non-opioid medication treatment options that serve as alternatives to opioid prescribing, including restorative therapies, behavioral health approaches, or integrative health therapies, such as acupuncture, chiropractic and osteopathic treatments, massage, or movement therapies. This plan shall be approved by the department as a component of the form filing and approval process.
II. Health carriers shall provide to covered persons who suffer from a chronic pain condition information regarding the pain management program and how to access services included in the program. Such information shall also be publicly available on the health carrier’s website.
III. Health carriers shall annually distribute educational materials about the program to providers within their networks.
IV. Health carriers shall not require a covered person to obtain prior authorization for access to the program of pain management.
V. Carriers may establish utilization controls, including prior authorization or step therapy requirements, for clinically appropriate non-opioid drugs approved by the United States Food and Drug Administration for the treatment or management of pain, but they shall not be more restrictive or extensive than the least restrictive or extensive utilization controls applicable to any clinically appropriate opioid drug.
3 Effective Date. This act shall take effect January 1, 2027.
25-0358
5/12/26
HB 241-FN- FISCAL NOTE
AS AMENDED BY THE SENATE (AMENDMENT # 2026-1622s)
FISCAL IMPACT:
Estimated State Impact | ||||
| FY 2026 | FY 2027 | FY 2028 | FY 2029 |
Revenue | $0 | Indeterminable Increase (range not provided by agency) | Indeterminable Increase (range not provided by agency) | Indeterminable Increase (range not provided by agency) |
Revenue Fund(s) | General Fund | |||
Expenditures* | $0 | $0 | $0 | $0 |
Funding Source(s) | None | |||
Appropriations* | $0 | $0 | $0 | $0 |
Funding Source(s) | None | |||
*Expenditure = Cost of bill *Appropriation = Authorized funding to cover cost of bill | ||||
| ||||
Estimated Political Subdivision Impact | ||||
| FY 2026 | FY 2027 | FY 2028 | FY 2029 |
County Revenue | $0 | $0 | $0 | $0 |
County Expenditures | $0 | Indeterminable | Indeterminable | Indeterminable |
Local Revenue | $0 | $0 | $0 | $0 |
Local Expenditures | $0 | Indeterminable | Indeterminable | Indeterminable |
METHODOLOGY:
This bill requires health carriers to develop programs providing access to a broad spectrum of covered pain management services for the management of chronic pain, including non-opioid treatment options, and limits certain utilization controls applicable to non-opioid pain treatments.
The Insurance Department states this bill could increase utilization of pain management services by requiring health carriers in the fully insured health insurance market to develop comprehensive pain management programs and limiting certain utilization controls for non-opioid pain treatments. Increased utilization of health care services could increase overall health care costs and result in higher insurance premiums. The extent to which utilization and health care costs may increase is indeterminable. To the extent health insurance premiums increase, Insurance Premium Tax revenue to the General Fund may also increase. To the extent counties and municipalities purchase health insurance, they could see an increase in health insurance premiums.
AGENCIES CONTACTED:
Insurance Department
| Date | Amendment |
|---|---|
| Nov. 10, 2025 | 2025-2990h |
| April 22, 2026 | 2026-1622s |
| Date | Body | Type |
|---|---|---|
| Jan. 23, 2025 | House | Hearing |
| March 5, 2025 | House | Exec Session |
| March 5, 2025 | House | Exec Session |
| Oct. 28, 2025 | House | Exec Session |
| Oct. 28, 2025 | House | Floor Vote |
| March 17, 2026 | House | Exec Session |
| March 17, 2026 | House | Floor Vote |
| April 8, 2026 | Senate | Hearing |
| Senate | Floor Vote |
May 21, 2026: House Concurs with Senate Amendment 2026-1622s (Rep. Hunt): MA VV 05/21/2026 HJ 14
May 5, 2026: Ought to Pass with Amendment # 2026-1622s, MA, VV; OT3rdg; 05/07/2026; SJ 11
May 5, 2026: Committee Amendment # 2026-1622s, AA, VV; 05/07/2026; SJ 11
April 22, 2026: Committee Report: Ought to Pass with Amendment # 2026-1622s, 05/07/2026; Vote 4-0; CC; SC 17
April 1, 2026: Hearing: 04/08/2026, Room 100, SH, 09:30 am; SC 13
March 30, 2026: Introduced 03/26/2026 and Referred to Health and Human Services; SJ 7
March 26, 2026: Ought to Pass: MA VV 03/26/2026 HJ 9
March 19, 2026: Committee Report: Ought to Pass 03/17/2026 (Vote 25-0; CC)
March 13, 2026: Executive Session: 03/17/2026 10:00 am GP 230
Feb. 13, 2026: Division I Work Session: 02/20/2026 11:00 am GP 230
Jan. 21, 2026: Division I Work Session: 02/09/2026 10:00 am GP 234
Jan. 7, 2026: Referred to Finance 01/07/2026 HJ 1 P. 44
Jan. 7, 2026: Ought to Pass with Amendment 2025-2990h: MA VV 01/07/2026 HJ 1 P. 43
Jan. 7, 2026: Amendment # 2025-2990h: AA VV 01/07/2026 HJ 1 P. 43
Nov. 10, 2025: Committee Report: Ought to Pass with Amendment # 2025-2990h (NT) 10/28/2025 (Vote 17-0; CC) HC 51 P. 3
Oct. 8, 2025: Executive Session: 10/28/2025 11:00 am GP 229
Sept. 22, 2025: Full Committee Work Session: 10/08/2025 10:00 am GP 229
Aug. 27, 2025: Full Committee Work Session: 09/10/2025 10:00 am GP 229
March 5, 2025: Retained in Committee
Feb. 13, 2025: Executive Session: 03/05/2025 10:00 am LOB 302-304
Feb. 13, 2025: Executive Session: 03/05/2025 10:00 am LOB 302-304
Feb. 20, 2025: Subcommittee Work Session: 03/04/2025 10:00 am LOB 104
Jan. 15, 2025: Public Hearing: 01/23/2025 01:45 pm LOB 302-304
Jan. 9, 2025: Vacated and Referred to Commerce and Consumer Affairs (Rep. W. MacDonald): MA VV (in recess of) 01/09/2025 HJ 3 P. 7
Jan. 7, 2025: Introduced 01/08/2025 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 12